Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any Link to your claim: "Saleen joins forces with Fisker's new company VFL Automotive"?
Obviously NO mention of Saleen here:
http://www.bloomberg.com/news/articles/2016-01-08/gm-icon-bob-lutz-henrik-fisker-announce-new-company-vfl-automotive
At this rate it will rather sooner than later show NO BID...
They have nice Cars, no doubt, but obviously Management has no Clue how to run a Company successful. Especially a public traded one...
Just read the Filings, no need to google anything, imo.
77M dumped this morning...
GL
A/S increased to 2.5Billion shares per NVSOS Filing
Previous Stock Value:
Par Value Shares: 1,750,000,000 Value: $ 0.001
Par Value Shares: 1,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 1,751,000.00
New Stock Value:
Par Value Shares: 2,500,000,000 Value: $ 0.001
Par Value Shares: 1,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 2,501,000.00
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=WVlwZ1cMNKqkU8sMdqFyeQ%253d%253d&CorpName=TEXHOMA+ENERGY%2c+INC.
Mine is still listed as "Abandoned"
Still no Permits?
LOL and GL
Namechange filed with the NVSOS
New Co Name: MEDICALLY MINDED, INC.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=hK%252bV4c%252fp2pe0%252bhdYozHeBg%253d%253d&nt7=0
AS increase has been reported already
New Sole Officer is now: ADAM S. TRACY
NVSOS got just updated again...
Namechange filed with the NVSOS ->
New Co Name: MOBICARD INC.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=mNXFb3B%252bIGPv45HcIPP%252fDA%253d%253d
Also a Stock Split filed...
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=mNXFb3B%252bIGPv45HcIPP%252fDA%253d%253d&CorpName=MOBICARD+INC.
Maybe just a wrong Form?
No change to the SS per the NVSOS
Namechange filed with the NVSOS
New Name -> MCGRAW NESTOR, INC.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=IUht1d1T2XYMZQ%252bzJPpFXQ%253d%253d&nt7=0
Oh it was just an answer to a question...
In Fact they aren't displaying and that's the Key imo.
Wondering where you saw that?
Link pls
No mention of having somebody there...
https://twitter.com/saleen
And here the ORG VIDEO FROM 2009 !!!
Uploaded on Jun 12, 2009
Silver Saleen S7 Twin Turbo
http://www.saleen.com
Dumty Dump...
Most Note Holders will now be able to convert in the .0001's
WOW unreal Move while shareholders will be wiped out...
Jan. 11, 2016 9:17 a.m. ET
American Apparel Inc. received a $300 million buyout offer, backed by former Chief Executive Dov Charney, months after the retailer filed for bankruptcy and [b[color=red]]unveiled a restructuring plan that would wipe out shareholders[/color].
I'm not into speculations, only reported the A/S increase as filed with the NVSOS.
If you like what the latest 10Q shows, do whatever you want. Your
$'s, your choise.
GL
Name change filed with the NVSOS ->
AMERICAN BRIVISION (HOLDING) CORPORATION
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=2V9vYMcB4jopDzD4AzUXHg%253d%253d&nt7=0
A/S increased to 350M
Company Age: 6 Months
http://www.bizapedia.com/de/AMERICAN-BRIVISION-CORPORATION.html
Facebook Acc created 30th Dec'15
https://www.facebook.com/ABVCbiomedical/
BioLite, Inc. formed an alliance with American BriVision Corporation (ABVC) to co-develop the US market for its new drugs
including combination therapy for Triple-negative breast cancer (TNBC), cancer combination therapy,
Hematology-Chronic Lymphocytic Leukemia (HCLL), Attention Deficit Hyperactivity Disorder(ADHD) and Major Depressive Disorder.
For the cancer combination therapy project, BioLite, Inc. has initiated the co-operation with an oversea partner, and is also technically
supported by a US renowned cancer center. These partners also came to support the BioLite-sponsored
International Symposium on Hematology & Oncology held in Oct., 2015, Taipei.
(Central News Agency reporters Luo Xiuwen Taipei October 1, 2015 e) The special Bio Board of Directors recently passed a major resolution, an alliance of US companies American BriVision Corporation (Code ABVC) to jointly develop the North American pharmaceutical market, the Department can obtain special authorization gold, milestone revenue and premium share.
US ABVC cooperation with international leading medical and research center for cancer, focusing on the blood-tumor drugs, central nervous system drugs and market development of high-end medical equipment, conduct clinical trials translational research industry, sublicense large international pharmaceutical companies, to open up global markets.
ABVC end of this year the system in the US OTC (Over-The-Counter Market) listing, and planning for 2018 in the US NASDAQ (NASDAQ) listed on the board.
The special Biotechnology (6458) focus on high-end medical materials, magnetic nano new formulations of new drugs, protein drugs, transdermal attract technology to develop new forms of patented layout of the world's major countries, has been jointly reviewed by the Ministry of Economic Affairs and the Ministry of Health, Welfare, with " high-end medical material "and" drug development "Pom new drugs Emerging biotech companies. The Board has invested 700 million yuan by the construction of the output value of billions of PIC / SGMP high-end medical material plant.
Wright, to join the United States Department of Special ABVC grab new drug markets in North America
Wright Medical Group's Health Department of Special biotechnology (6458-TW) and Wright Biomedical alliance ABVC US companies (American BriVision Corporation), to jointly develop the North American market for triple-negative breast cancer, solid tumors Anti-PD1, chronic lymphocytic leukemia, severe depression therapy clinical trials with attention deficit hyperactivity disorder psychosis 5, and insulin transdermal system of import and sales rights market.
Wright said another international market attention, "chronic lymphocytic leukemia combination therapy" with Japan strategic alliance partners to develop from the start of clinical Phase II and get top-ranked American Cancer tumor medical research institutions technical support.
Wright pointed out that cancer tumors has sent four world-class research institutions and scholars with a number of researchers, support 2015 International Symposium exclusive association with blood tumor diseases, respectively Speaker efficacy of herbal maitake extract anticancer aspects, MBG in the hematopoietic system and the effect on the immune system, natural medicine and hematologic malignancies overview, botanical extracts used in combination in the treatment of chronic lymphocytic leukemia. Bring the world's latest medical information and advanced treatment methods for Taiwan's blood cancer specialist.
Wright pointed out closer, "chronic lymphocytic leukemia plant new drug combination therapy," Taiwan's innovative technology is based on a starting point, combined with maitake extract plant factories Japan strategic partnership, cooperation and America's top cancer tumor clinical trials of medical research institutes, three strong contribution to the effort to work together all health development goals, to build Taiwan's biotech industry and international health research linking innovation model.
A/S increased to 1.4 BILLION shares per NVSOS Filing
Previous Stock Value:
Par Value Shares: 650,000,000 Value: $ 0.001
Par Value Shares: 100,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 750,000.00
New Stock Value:
Par Value Shares: 1,400,000,000 Value: $ 0.001
Par Value Shares: 100,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 1,500,000.00
A/S increased to 5 BILLION shares per NVSOS Filing
Previous Stock Value:
Par Value Shares: 10,000,000 Value: $ 0.001
Par Value Shares: 2,000,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 2,010,000.00
New Stock Value:
Par Value Shares: 10,000,000 Value: $ 0.001
Par Value Shares: 5,000,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 5,010,000.00
You are reading way too much into it.
...used to shake shares...
LOL
BMAK is just selling the converted shares from the toxic Lenders for ~40-60% gain. Since the Price hit .0004 yesterday some notes can be converted already in the .0001's
Just read the Terms.
...shaking shares... lol
Toxic Note Conversion ongoing -> BMAK
GL
Of course you are able to deliver proof for your claim, right?
Shorting a subpenny?? LMAO
GL with that.
Dream on Man !!
Running out of stuff to pump eh?
That's from 2013 !!
http://news.boldride.com/2013/12/saleen-announces-electric-vehicle-production/40633/
Why don't you show the source right away?
Most likely the Float is actually close to 1B, imo.
It would be easy to verify, but since the TA is gagged...
I'm saying the float has reached 489 mil.
Just read the Terms for the Debt Notes...
anywhere between 40-60% off of the lowest trading price during the last 5-10 trading days
Dump Fest today... nasty toxic debt...
From 2morrow on the Note Holders will be able to convert in the .0002's
Wondering if the O/S has exceeded 1B already.
and again, what has this Post to do with SLNN?
Will he... ? and even IF, what has it to do with SLNN?
NOTHING !
an Aston Martin public-relations representative in the U.S., said the company believes the lawsuit is without merit
Earlier this year Aston Martin sued Mr. Fisker over another car design, called the Thunderbolt. The two parties settled that case, and the Thunderbolt is no longer slated for production, according to Mr. Michaels.
NOTHING since SLNN wasn't the Seller
Are you talking about Mr S.Etzelsberger?
EX VP of Advanced Engineering
Saleen
June 2013 – April 2015 (1 year 11 months)
Current:
Chief Technology Officer | Co-Founder
Urban626, LLC
April 2015 – Present (10 months)
https://www.linkedin.com/in/sven-etzelsberger-85b40a15
That Video is from 2014,
per their latest Filings the Company is obviously struggling to pay their monthly bills.
GL
NVSOS -> Merge In Filing and massive R/S, imo
File Date: 12/31/2015
Effective Date: 1/1/2016
Previous Stock Value:
Par Value Shares: 100,000,000 Value: $ 0.001
Par Value Shares: 5,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 105,000.00
New Stock Value:
Par Value Shares: 5,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 5.00
A/S increased to 1 BILLION shares per NVSOS
File Date: 12/31/2015
Previous Stock Value:
Par Value Shares: 500,000,000 Value: $ 0.001
Par Value Shares: 20,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 520,000.00
New Stock Value:
Par Value Shares: 1,000,000,000 Value: $ 0.001
Par Value Shares: 20,000,000 Value: $ 0.001
No Par Value Shares: 0
Total Authorized Capital: $ 1,020,000.00
That's a Rumor, not a fact...
per YOUR OWN POST ->
Rumors suggest that it will be based on Chevrolet’s Corvette Stingray.
Any proof for your claim?
My guess is as good as yours, imo.
I can help you with that ->
http://www.imsa.com/drivers/michael-levitas
Could the Fisker Force 1 be a Dodge Viper with New Skin?
Henrik Fisker has announced that he will debut a new American supercar at the 2016 Detroit Auto Show and based on the sparse details, the Dodge Viper could be the base on which Fisker’s new Force 1 is built – with a price tag of just under $300,000.
Henrik Fisker is one of the most well-known men in the modern automotive world and based on a new press release, I think that the former electric car company owner and BMW/Aston Martin designer could be turning his attention to the Dodge Viper. The statement offers some vague details on the Fisker Force 1 – an American built supercar which will make its grand debut at the 2016 North American International Auto Show in Detroit. The release talks about the car a great deal without actually offering any concrete facts about the car, but based on the few details offered up, it most certainly sounds like Fisker’s Force 1 could be based on the Dodge Viper.
Should that be the case, the Fisker Force 1 would follow up on the Fisker Galpin Rocket Mustang, which debuted last year with a unique look and 725 supercharged horsepower.
The Fisker Force 1
So here is what we know about the Fisker Force 1, in addition to what we can see in the drawing above:
Front-mid engine chassis design
All carbon fiber body
Ultra Thin Ventilated (UTV) laser blade tail lamps
2-seat interior
21 inch wheels on Pirelli P Zero Tires
New active suspension
The world's highest output natural aspirated engine
Manufactured in Michigan
6-speed manual transmission or paddle shifted auto
Price starting just under $300,000
Force 1 will debut on January 12th in Detroit
The Dodge Viper is a front-mid engine chassis design with a 2-seat interior, active suspension, it has one of world’s highest output naturally aspirated engines, a 6-speed manual transmission and it is manufactured in Michigan. The carbon fiber body would be unique to the Force 1, as would the taillights, the wheels and the automatic transmission. Also, in looking at the sketch above, I could most certainly see the Dodge Viper chassis tucking under that body with the long hood and short rear end. The Viper is already one of the most powerful naturally aspirated cars sold in the world, so Fisker wouldn’t need to beef the engine up at all in putting the Force 1 among the world’s most powerful.
Most importantly, the Dodge Viper would be readily available for Fisker’s team to transform them into the Force 1, and I can imagine that the Chrysler Group would love to sell 50 Vipers – even if they are going to be rebodied and sold under a completely different name.
Of course, I could be totally off-base with my guess that the Fisker Force 1 will be based on the Dodge Viper, but the details sure seem to match up pretty nicely. It could also be based on the Corvette, but the Corvette is in incredibly high demand and the LT1 would need a great deal of work to be one of the most powerful naturally aspirated engines in the world.
Should any more information surface, you will be sure to find it here on TorqueNews.com, but if nothing else, you will find all of the information on the Fisker Force 1 here when the car debuts next month in Detroit!
http://www.torquenews.com/106/could-fisker-force-1-be-dodge-viper-new-skin
Very interesting read, imo!
The future of car suspension is here: DSC Sport’s active shocks in action
How about Mike Levitas (DSC Sports) active Suspension System?
Imo the perfect fit for Fisker's Force1!
http://arstechnica.com/cars/2015/07/the-future-of-car-suspension-is-here-dsc-sports-active-shocks-in-action/
IF you have it, why don't you post the Email with the actual O/S?
Typical BS imo.
TA is gagged no matter how you twist it.
Actual O/S should be ~800M if not closer to 1B imo